Radiation Oncology/Therapy: Page 124

New MRI agent shows promise for tumors

By AuntMinnie.com staff writers

Researchers from the University of Massachusetts have developed a protein-based MRI contrast agent that targets tumors and can be easily cleared by the body, according to a paper published online June 5 in Nano Letters.

July 6, 2017

FDA responds to IsoRay's GammaTile 510(k)

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has issued a response to medical isotope developer IsoRay's pending 510(k) application for its GammaTile radiation therapy system.

July 5, 2017

IBA inks Va. installation deal

By AuntMinnie.com staff writers

Proton therapy developer Ion Beam Applications (IBA) will install its Proteus Plus cancer treatment proton therapy system for Inova Health Care Services in Falls Church, VA.

July 4, 2017

Sirtex highlights research on colorectal cancer survival

By AuntMinnie.com staff writers

Cancer treatment firm Sirtex Medical is highlighting research showing that the addition of selective internal radiation therapy to standard first-line chemotherapy may improve overall survival in metastatic colorectal cancer patients with right-sided primary tumors, compared with those receiving chemotherapy alone.

July 2, 2017

ASTRO bestows grants to survivor groups

By AuntMinnie.com staff writers

The American Society for Radiation Oncology (ASTRO) has named two recipients of its Survivor Circle grants.

June 28, 2017

FDA clears Varian's Halcyon rad therapy system

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared radiation oncology firm Varian Medical Systems' Halcyon platform for radiation therapy.

June 28, 2017